Exploiting Recent Innovations in Analytical Technology to Achieve Improved Understanding and Control of Complex Biotherapeutics - Technical Seminar Sponsored by Waters Corporation

We welcome you to attend the WCBP 2021 Waters Technical Seminar, where we will cover several recent innovations in separations and mass detection, that will enable biopharmaceutical organizations to obtain better data more effectively. You will learn about the recent development of Waters High Performance Surface (HPS) technology, and the positive impacts that it can provide on bioseparations performance, efficiency, and robustness. We will also detail new capabilities of the BioAccord LC-MS System that continues to make LC-MS attribute-based analysis accessible to experts and non-MS experts alike across a biopharmaceutical organization.

Our guest speaker, Francesco Lanucara (Allergan, Liverpool, UK) will describe his group’s efforts to gain insights on Adeno-Associated Virus (AAV) capsid structures through multi-level LC-MS analysis. This complex gene therapy and vaccine delivery platform is subject to evolving regulatory expectations for both attribute characterization and monitoring. Allergan will be presenting their work with the BioAccord LC-MS System for attribute definition and transferring this knowledge into higher throughput monitoring assays, and potential automated attribute-based methods for AAV analysis within the highly regulated QC environment.